Impact of Delayed Treatment of Hereditary Angioedema Attacks: Insights from Patient Surveys from Europe

Kalvista Pharmaceuticals Inc. published this content on October 02, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 10, 2025 at 18:57 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]